KARI SCULATI: Open Payments
NPI 1508481334 · GRANGER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 87 payments from 19 companies in 2025. Trend: 2023 $503 · 2024 $1,151 · 2025 $1,891
Food & beverage: $1,836Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $371 |
| Galderma Laboratories, L.P. | 13 | $254 |
| GENZYME CORPORATION | 5 | $196 |
| Regeneron Healthcare Solutions, Inc. | 3 | $163 |
| UCB, Inc. | 8 | $159 |
| Arcutis Biotherapeutics, Inc. | 4 | $157 |
| Novartis Pharmaceuticals Corporation | 7 | $117 |
| Janssen Biotech, Inc. | 3 | $85 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Genentech USA, Inc. | 2 | $59 |
Products named: DUPIXENT, RINVOQ, NEMLUVIO, Bimzelx, Zoryve, SKYRIZI, TREMFYA, ACTHAR.
Industry payments across IN — which companies pay providers there.
